Our Pipeline
ONO is investigating additional molecules across our four focus areas in clinical trials around the world.
![Lab technician](/sites/default/files/2024-07/Pipeline_Hero.webp)
57
Clinical trial sites in the U.S.
5
Clinical trials ongoing in the U.S.
Combination with nivolumab
Mechanism
Disease Area
Country
Licensor
Development Phase
Neurology
Phase 1
Phase 2
Phase 3
Filing
Approval
P1
P2
P3
F
A
ONO-1110
Endocannabinoid regulation
ONO-2020
Epigenetic regulation
ONO-2808
S1P5 receptor agonist
ONO-2910
Enhancement of Schwann cell differentiation
INNOVATION AROUND THE WORLD
Our Global Pipeline
ONO is investigating additional therapeutics across our four focus areas globally.
![Our Global Pipeline](/sites/default/files/2023-11/Pipeline_Global.png)
![Contact Us](/sites/default/files/2023-11/AboutUs_BottomLinks_Contact.png)
Get in touch to learn more.
![Work@ONO](/sites/default/files/2023-11/OurScience_BottomLinks_WorkAtONO.png)
Explore what it’s like to work at ONO PHARMA USA.